# Digoxin Evaluation in Chronic Heart Failure: Investigational Study In Outpatients in the Netherlands

Study · id `cardio:ct-nct03783429` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03783429](<https://clinicaltrials.gov/study/NCT03783429>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03783429

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems; Heart failure  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 982 participants.

## Technical summary

Registry record NCT03783429. Randomized; quadruple masking; primary purpose treatment. Start 2020-07-01 (actual); primary completion 2025-11-13 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 982 participants (enrolled count; ClinicalTrials.gov record NCT03783429, source copy `cardio:ctgov-nct03783429-2026-04-27`, retrieved 2026-10-26)
- Started: 2020-07-01 (actual) (ClinicalTrials.gov record NCT03783429, source copy `cardio:ctgov-nct03783429-2026-04-27`, retrieved 2026-10-26)
- Primary completion: 2025-11-13 (actual) (ClinicalTrials.gov record NCT03783429, source copy `cardio:ctgov-nct03783429-2026-04-27`, retrieved 2026-10-26)
- Completion: 2025-11-13 (actual) (ClinicalTrials.gov record NCT03783429, source copy `cardio:ctgov-nct03783429-2026-04-27`, retrieved 2026-10-26)
- Countries: Netherlands (ClinicalTrials.gov record NCT03783429, source copy `cardio:ctgov-nct03783429-2026-04-27`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03783429-2026-04-27`, retrieved 2026-10-26)

## The registry's words

- Brief title: Digoxin Evaluation in Chronic Heart Failure: Investigational Study In Outpatients in the Netherlands
- Acronym: DECISION
- Condition: Heart Failure
- Intervention (Drug): Digoxin
- Intervention (Drug): Placebos
- Lead sponsor: University Medical Center Groningen
- Lead sponsor class: OTHER
- Collaborator: Disphar International B.V.
- Collaborator class: INDUSTRY
- Collaborator: Teva Nederland BV
- Collaborator class: UNKNOWN
- Collaborator: Tiofarma BV
- Collaborator class: UNKNOWN
- Collaborator: Netherlands Heart Foundation
- Collaborator class: OTHER
- Collaborator: Werkgroep Cardiologische centra Nederland
- Collaborator class: UNKNOWN

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry lists this organization as the lead sponsor: University Medical Center Groningen (`cardio:org-university-medical-center-groningen`)
- Registry lists this organization as a collaborator: Netherlands Heart Foundation (`cardio:org-netherlands-heart-foundation`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Low-dose digoxin in patients with heart failure with reduced or mildly reduced ejection fraction: a randomized controlled trial (`cardio:pubmed-42108270`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 41a779d9bef0890ddac134e593019e5447e0edc9b1338d24b88551fa62a6aec5
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
